Developments in cardiac transplantation.
Cardiac transplantation has matured as a therapeutic intervention, allowing definitive treatment of critically ill children and adults with end-stage heart disease. The ongoing critical shortage of donor organs continues to deny hundreds of individuals access to this intervention. Accordingly, many of the most meaningful recent advances made in the field of cardiac transplantation involve means of expanding our donor pool. While current immunosuppressive regimens have been considerably successful in the management of acute cellular rejection, management of the problems of acute and chronic vascular rejection remains disappointing. Advances in this arena remain particularly urgent for physicians and surgeons involved in the care of heart transplant recipients.
Nisco
S J
SJ
Stanford University School of Medicine, Department of Cardiothoracic Surgery, CA 94305.
Reitz
B A
BA
D000328:Adult; D002648:Child; D005500:Follow-Up Studies; D006331:Heart Diseases / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D016027:Heart Transplantation / Q000379:methods* / Q000401:mortality / Q000502:physiology; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D011182:Postoperative Care / Q000379:methods; D011183:Postoperative Complications / Q000401:mortality / Q000503:physiopathology / Q000601:surgery; D012086:Reoperation; D015996:Survival Rate